BR9915938A - Pyrimidine derivatives replaced by aryl and heterocyclyl as anticoagulants - Google Patents

Pyrimidine derivatives replaced by aryl and heterocyclyl as anticoagulants

Info

Publication number
BR9915938A
BR9915938A BR9915938-4A BR9915938A BR9915938A BR 9915938 A BR9915938 A BR 9915938A BR 9915938 A BR9915938 A BR 9915938A BR 9915938 A BR9915938 A BR 9915938A
Authority
BR
Brazil
Prior art keywords
anticoagulants
heterocyclyl
aryl
pyrimidine derivatives
derivatives replaced
Prior art date
Application number
BR9915938-4A
Other languages
Portuguese (pt)
Inventor
David D Davey
Gary B Phillips
Original Assignee
Berlex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Lab filed Critical Berlex Lab
Publication of BR9915938A publication Critical patent/BR9915938A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE PIRIMIDINIA SUBSTITUìDOS POR ARILA E HETEROCICLILA COMO ANTICOAGULANTES"<D>. Esta invenção é direcionada aos derivados de pirimidina substituída por arila e heterociclila selecionados das fórmulas (I), (II) e (III) em que Z , Z , R , R , R , R^ 4^, R^ 5^ e R^ 6^ são aqui definidos. Estes compostos são úteis como anticoagulantes.Invention Patent: <B> "PYRIMIDINY DERIVATIVES REPLACED BY ARYL AND HETEROCYCLYL AS ANTICOAGULANTS" <D>. This invention is directed to aryl and heterocyclyl-substituted pyrimidine derivatives selected from formulas (I), (II) and (III) where Z, Z, R, R, R, R ^ 4 ^, R ^ 5 ^ and R ^ 6 ^ are defined here. These compounds are useful as anticoagulants.

BR9915938-4A 1998-12-04 1999-12-03 Pyrimidine derivatives replaced by aryl and heterocyclyl as anticoagulants BR9915938A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/205,498 US6127376A (en) 1998-12-04 1998-12-04 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
PCT/US1999/028537 WO2000033844A1 (en) 1998-12-04 1999-12-03 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants

Publications (1)

Publication Number Publication Date
BR9915938A true BR9915938A (en) 2001-08-21

Family

ID=22762435

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915938-4A BR9915938A (en) 1998-12-04 1999-12-03 Pyrimidine derivatives replaced by aryl and heterocyclyl as anticoagulants

Country Status (26)

Country Link
US (2) US6127376A (en)
EP (1) EP1135131A4 (en)
JP (1) JP2002531506A (en)
KR (1) KR20010093799A (en)
CN (1) CN1329491A (en)
AU (1) AU760370B2 (en)
BG (1) BG105557A (en)
BR (1) BR9915938A (en)
CA (1) CA2354040A1 (en)
CZ (1) CZ20011932A3 (en)
EE (1) EE200100298A (en)
HR (1) HRP20010499A2 (en)
HU (1) HUP0104508A3 (en)
IL (2) IL143347A0 (en)
LT (1) LT4912B (en)
LV (1) LV12783B (en)
MX (1) MXPA01005656A (en)
NO (1) NO20012701L (en)
NZ (1) NZ512104A (en)
PL (1) PL348034A1 (en)
RO (1) RO120971B1 (en)
RU (1) RU2001118466A (en)
SI (1) SI20637A (en)
SK (1) SK7632001A3 (en)
WO (1) WO2000033844A1 (en)
ZA (1) ZA200104235B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0813525T3 (en) 1995-03-10 2004-02-16 Berlex Lab Benzamidine derivatives, their preparation and use as anticoagulants
US6686364B2 (en) 1997-12-08 2004-02-03 Berlex Laboratories, Inc. Benzamidine derivatives and their use as anti-coagulants
US6262088B1 (en) * 1998-11-19 2001-07-17 Berlex Laboratories, Inc. Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
US6350761B1 (en) 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
US7122544B2 (en) 2000-12-06 2006-10-17 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
US7129242B2 (en) 2000-12-06 2006-10-31 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US7351729B2 (en) 2002-03-08 2008-04-01 Signal Pharmaceuticals, Llc JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
ATE451104T1 (en) * 2002-07-29 2009-12-15 Rigel Pharmaceuticals Inc METHOD FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES USING 2,4-PYRIMIDINEDIAMINE COMPOUNDS
TW200410945A (en) * 2002-08-08 2004-07-01 Amgen Inc Vanilloid receptor ligands and their use in treatments"
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
PL1656372T3 (en) 2003-07-30 2013-08-30 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
WO2005047268A2 (en) * 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use
US7557207B2 (en) 2004-11-24 2009-07-07 Rigel Pharmaceuticals, Inc. Spiro 2,4-pyrimidinediamine compounds and their uses
BRPI0606318B8 (en) 2005-01-19 2021-05-25 Rigel Pharmaceuticals Inc compound, composition, and use of a compound
JP2008540436A (en) * 2005-05-03 2008-11-20 ライジェル ファーマシューティカルズ， インコーポレイテッド JAK kinase inhibitors and uses thereof
CN101495462B (en) * 2006-07-21 2012-03-21 诺瓦提斯公司 Pyrimidine derivatives and their use as pesticides
NZ589315A (en) * 2008-04-16 2012-11-30 Portola Pharm Inc 2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors
US8138339B2 (en) 2008-04-16 2012-03-20 Portola Pharmaceuticals, Inc. Inhibitors of protein kinases
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
HUE035029T2 (en) 2008-05-21 2018-03-28 Ariad Pharma Inc Phosphorous derivatives as kinase inhibitors
SG10201510696RA (en) 2008-06-27 2016-01-28 Celgene Avilomics Res Inc Heteroaryl compounds and uses thereof
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
US11351168B1 (en) 2008-06-27 2022-06-07 Celgene Car Llc 2,4-disubstituted pyrimidines useful as kinase inhibitors
US8278084B2 (en) 2009-02-11 2012-10-02 Northwestern University Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
US8932842B2 (en) 2009-02-11 2015-01-13 Northwestern University Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
ES2659725T3 (en) 2009-05-05 2018-03-19 Dana-Farber Cancer Institute, Inc. EGFR inhibitors and disorder treatment procedure
CN103096716B (en) 2010-08-10 2016-03-02 西建阿维拉米斯研究公司 The benzene sulfonate of BTK inhibitor
BR112013010564B1 (en) 2010-11-01 2021-09-21 Celgene Car Llc HETEROCYCLIC COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
WO2012061303A1 (en) 2010-11-01 2012-05-10 Avila Therapeutics, Inc. Heteroaryl compounds and uses thereof
WO2012064706A1 (en) 2010-11-10 2012-05-18 Avila Therapeutics, Inc. Mutant-selective egfr inhibitors and uses thereof
JP5999177B2 (en) 2011-05-04 2016-09-28 アリアド・ファーマシューティカルズ・インコーポレイテッド Compound for inhibiting cell proliferation of EGFR-activated cancer
TW201325593A (en) 2011-10-28 2013-07-01 Celgene Avilomics Res Inc Methods of treating a BRUTON'S tyrosine kinase disease or disorder
MX363551B (en) 2011-11-23 2019-03-27 Portola Pharmaceuticals Inc Star Pyrazine kinase inhibitors.
SG11201405692UA (en) 2012-03-15 2014-10-30 Celgene Avilomics Res Inc Salts of an epidermal growth factor receptor kinase inhibitor
WO2013138495A1 (en) 2012-03-15 2013-09-19 Celgene Avilomics Research, Inc. Solid forms of an epidermal growth factor receptor kinase inhibitor
AU2013204563B2 (en) 2012-05-05 2016-05-19 Takeda Pharmaceutical Company Limited Compounds for inhibiting cell proliferation in EGFR-driven cancers
WO2014100748A1 (en) 2012-12-21 2014-06-26 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
WO2014124230A2 (en) 2013-02-08 2014-08-14 Celgene Avilomics Research, Inc. Erk inhibitors and uses thereof
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
US9492471B2 (en) 2013-08-27 2016-11-15 Celgene Avilomics Research, Inc. Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
US9415049B2 (en) 2013-12-20 2016-08-16 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
US10005760B2 (en) 2014-08-13 2018-06-26 Celgene Car Llc Forms and compositions of an ERK inhibitor
CN109897005B (en) * 2019-04-12 2022-07-22 湖南省农业生物技术研究所 Phenyl pyrimidine analogue containing substituted phenoxy, preparation method and application thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB824908A (en) * 1958-06-03 1959-12-09 May & Baker Ltd Improvements in or relating to triazine derivatives
JPS5922697B2 (en) * 1976-01-13 1984-05-28 エーザイ株式会社 Bis-(meta-amidinophenoxy)-compound
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
DE69321344D1 (en) * 1992-02-14 1998-11-05 Corvas Int Inc INHIBITORS OF THROMBOSE
DE4213919A1 (en) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K CYCLIC IMINODERIVATES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
IL106324A (en) * 1992-07-17 1998-09-24 Shell Int Research Substituted pyrimidine compounds their preparation some novel intermediates thereof and acaricidal and insecticidal compositions containing them
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
EP0675899B1 (en) * 1992-12-15 1999-03-17 Corvas International, Inc. NOVEL INHIBITORS OF FACTOR Xa
US5332822A (en) * 1992-12-24 1994-07-26 Bristol-Myers Squibb Company Heteroaromatic and thioheteroaromatic substituted sulfonamide thrombin inhibitors
CA2155931C (en) * 1993-02-12 2002-11-19 George Phillip Vlasuk Inhibitors of thrombosis
US5633381A (en) * 1994-07-05 1997-05-27 Berlex Laboratories, Inc. (Z,Z), (Z,E) and (E,Z) isomers of substituted bis(phenylmethylene)cycloketones
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
US5691364A (en) * 1995-03-10 1997-11-25 Berlex Laboratories, Inc. Benzamidine derivatives and their use as anti-coagulants
DK0813525T3 (en) 1995-03-10 2004-02-16 Berlex Lab Benzamidine derivatives, their preparation and use as anticoagulants
US5612363A (en) * 1995-06-02 1997-03-18 Berlex Laboratories, Inc. N,N-di(aryl) cyclic urea derivatives as anti-coagulants
US5849759A (en) * 1995-12-08 1998-12-15 Berlex Laboratories, Inc. Naphthyl-substituted benzimidazole derivatives as anti-coagulants
US5994375A (en) * 1996-02-12 1999-11-30 Berlex Laboratories, Inc. Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
US5693641A (en) * 1996-08-16 1997-12-02 Berlex Laboratories Inc. Bicyclic pyrimidine derivatives and their use as anti-coagulants
US5753635A (en) * 1996-08-16 1998-05-19 Berlex Laboratories, Inc. Purine derivatives and their use as anti-coagulants
CZ86199A3 (en) * 1996-09-12 1999-08-11 Schering Aktiengesellschaft Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroacid derivatives, pharmaceutical composition containing such compounds and their use as anticoagulant agents
US6008234A (en) 1996-09-12 1999-12-28 Berlex Laboratories, Inc. Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
US6004985A (en) * 1996-10-09 1999-12-21 Berlex Laboratories, Inc. Thio acid derived monocylic N-heterocyclics as anticoagulants
CA2293824A1 (en) * 1997-06-19 1998-12-23 Mimi Lifen Quan (amidino)6-membered aromatics as factor xa inhibitors
CA2315070A1 (en) 1997-12-17 1999-07-01 Schering Aktiengesellschaft Ortho-anthranilamide derivatives as anti-coagulants

Also Published As

Publication number Publication date
PL348034A1 (en) 2002-05-06
SI20637A (en) 2002-02-28
IL143347A (en) 2006-12-10
EP1135131A1 (en) 2001-09-26
HUP0104508A3 (en) 2002-07-29
IL143347A0 (en) 2002-04-21
KR20010093799A (en) 2001-10-29
LV12783B (en) 2002-10-20
NO20012701L (en) 2001-07-25
EE200100298A (en) 2002-12-16
US6127376A (en) 2000-10-03
LT4912B (en) 2002-04-25
SK7632001A3 (en) 2001-12-03
HRP20010499A2 (en) 2003-04-30
ZA200104235B (en) 2002-08-23
US6372751B1 (en) 2002-04-16
WO2000033844A1 (en) 2000-06-15
CZ20011932A3 (en) 2001-10-17
NZ512104A (en) 2003-10-31
AU3107500A (en) 2000-06-26
JP2002531506A (en) 2002-09-24
LV12783A (en) 2002-01-20
NO20012701D0 (en) 2001-06-01
LT2001061A (en) 2001-12-27
AU760370B2 (en) 2003-05-15
EP1135131A4 (en) 2002-01-02
RO120971B1 (en) 2006-10-30
CN1329491A (en) 2002-01-02
HUP0104508A2 (en) 2002-05-29
MXPA01005656A (en) 2002-04-24
RU2001118466A (en) 2003-04-20
CA2354040A1 (en) 2000-06-15
BG105557A (en) 2001-12-29

Similar Documents

Publication Publication Date Title
BR9915938A (en) Pyrimidine derivatives replaced by aryl and heterocyclyl as anticoagulants
PT1040108E (en) ORTHOPHANYLAMIDE DERIVATIVES AS ANTICOAGULANTS
FI903331A0 (en) KINAZOLINONER SUBSTITUERADE, VILKA AER ANVAENDBARA SOM ANGIOTENSIN-II-ANTAGONISTER.
ATE356119T1 (en) PYRIMIDINONE AS A MELANIN CONCENTRATING HORMONE RECEPTOR 1
ES2184070T3 (en) DERIVATIVES OF SUBSTITUTED OXIMES USEFUL AS ANTAGONISTS OF NEUROQUININA.
DE69803907D1 (en) Fungicides 2-methoxybenzophenones
BR9804214A (en) Compounds.
ATE288908T1 (en) MONOCYCLIC N-HETEROCYCLIC THIOACID DERIVATIVES AS ANTICOAGULANT
CY1109886T1 (en) New compounds as anti-inflammatory, immunomodulatory and anti-hypoplastic agents
NO20041493L (en) Chemical connections.
DE69721008D1 (en) BICYCLIC PYRIMIDINE DERIVATIVES AND THEIR USE AS ANTICOAGULANTS
MA27991A1 (en) AMINOQUINOLINE DERIVATIVES AND THEIR USE AS LIGANDS OF ADENOSINE A3
ES2183340T3 (en) PROCEDURE FOR THE PREPARATION OF COMPOUNDS OF 4-BROMOMETIL-BIFENILO.
DE60207759D1 (en) PYRIMIDOTRIAZINE AS PHOSPHATASEINHIBITORS
DE60336735D1 (en) NEW BIOLOGICAL MOLEKÜ LE
EA200400454A1 (en) MUSCARIN AGONISTS
BR9902084A (en) Heterocycles.
ATE496056T1 (en) PYRIMIDINE COMPOUNDS WITH PHOSPHONATE GROUPS AS ANTIVIRAL NUCLEOTIDE ANALOGS
BR0115996A (en) Sulfamidothienopyrimidines
BRPI0416678A (en) pyrazolpyrimidines
EA200100040A1 (en) CHEMICAL SYNTHESIS OF MORFOLINE DERIVATIVES
DE60041001D1 (en) SUBSTITUTED HOMOPIPERIDYLBENZIMIDAZOLANALOGA AS FUNDUSRELAXANTIA
EA200200727A1 (en) NEW INDOL DERIVATIVES
BR0012481A (en) Deacylation process for lipodepsipeptides
DK0915858T3 (en) Intermediates for the preparation of 2-imidazolin-5-ones

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DE RPI 1999 DE 28/04/2009.